These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3047924)
21. Outcome of kidney transplants in patients known to be flow cytometry crossmatch positive. Scornik JC; Clapp W; Patton PR; Van der Werf WJ; Hemming AW; Reed AI; Howard RJ Transplantation; 2001 Apr; 71(8):1098-102. PubMed ID: 11374409 [TBL] [Abstract][Full Text] [Related]
22. Pre-transplant donor specific antibody and its clinical significance in kidney transplantation. Thammanichanond D; Ingsathit A; Mongkolsuk T; Rattanasiri S; Kantachuvesiri S; Sakhonrat C; Leenanupan C; Worawichawongs S; Kitpoka P Asian Pac J Allergy Immunol; 2012 Mar; 30(1):48-54. PubMed ID: 22523907 [TBL] [Abstract][Full Text] [Related]
23. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity. Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580 [TBL] [Abstract][Full Text] [Related]
24. The flow cytometric crossmatch and early renal transplant loss. Mahoney RJ; Ault KA; Given SR; Adams RJ; Breggia AC; Paris PA; Palomaki GE; Hitchcox SA; White BW; Himmelfarb J Transplantation; 1990 Mar; 49(3):527-35. PubMed ID: 2138366 [TBL] [Abstract][Full Text] [Related]
25. Crossmatch procedures used in organ transplantation. Gebel HM; Lebeck LK Clin Lab Med; 1991 Sep; 11(3):603-20. PubMed ID: 1934966 [TBL] [Abstract][Full Text] [Related]
26. Luminex Solid-Phase Crossmatch for De Novo Donor-Specific Antibodies in Living-Donor Related Transplants. Mehrotra S; Sharma RK; Mayya M; Gupta A; Prasad N; Kaul A; Bhadauria DS Exp Clin Transplant; 2017 Aug; 15(4):394-399. PubMed ID: 28447925 [TBL] [Abstract][Full Text] [Related]
27. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch. Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518 [TBL] [Abstract][Full Text] [Related]
28. Fewer acute rejection episodes and improved outcome in kidney-transplanted patients with selection criteria based on crossmatching. Karuppan SS; Lindholm A; Möller E Transplantation; 1992 Mar; 53(3):666-73. PubMed ID: 1549863 [TBL] [Abstract][Full Text] [Related]
29. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients. Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967 [TBL] [Abstract][Full Text] [Related]
30. Identification of the antibody to vascular endothelial cells in patients undergoing cardiac transplantation. Brasile L; Zerbe T; Rabin B; Clarke J; Abrams A; Cerilli J Transplantation; 1985 Dec; 40(6):672-5. PubMed ID: 3907041 [TBL] [Abstract][Full Text] [Related]
31. Failure of anti-CD20 monoclonal antibody therapy to prevent antibody-mediated rejection in three crossmatch-positive renal transplant recipients. Matignon M; Tagnaouti M; Audard V; Dahan K; Lang P; Grimbert P Transplant Proc; 2007 Oct; 39(8):2565-7. PubMed ID: 17954175 [TBL] [Abstract][Full Text] [Related]
32. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization. Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237 [TBL] [Abstract][Full Text] [Related]
33. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation. Le Bas-Bernardet S; Hourmant M; Valentin N; Paitier C; Giral-Classe M; Curry S; Follea G; Soulillou JP; Bignon JD Transplantation; 2003 Feb; 75(4):477-82. PubMed ID: 12605113 [TBL] [Abstract][Full Text] [Related]
35. HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome. Christiaans MH; van Hooff JP; Nieman F; van den Berg-Loonen EM Transplantation; 1999 Apr; 67(7):1029-35. PubMed ID: 10221489 [TBL] [Abstract][Full Text] [Related]
36. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death. Fidler SJ; Irish AB; Lim W; Ferrari P; Witt CS; Christiansen FT Transpl Immunol; 2013 Jun; 28(4):148-53. PubMed ID: 23665534 [TBL] [Abstract][Full Text] [Related]
37. The good, the bad, and the ugly of luminex donor-specific crossmatch. Chowdhry M; Makroo RN; Thakur Y; Sharma V; Singh M; Kumar M HLA; 2018 Jun; 91(6):501-506. PubMed ID: 29457879 [TBL] [Abstract][Full Text] [Related]
38. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody. Shoker A; Klassen J; Herbut B Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455 [TBL] [Abstract][Full Text] [Related]
39. Clinical Relevance of Pretransplant Testing for Anti-Human Leukocyte Antigen Antibodies in Iraqi Renal Transplant Patients. Ali A; Al-Kaisi A; Ali I Exp Clin Transplant; 2019 Jan; 17(Suppl 1):164-168. PubMed ID: 30777546 [TBL] [Abstract][Full Text] [Related]
40. Utility of the virtual crossmatch in solid organ transplantation. Amico P; Hönger G; Steiger J; Schaub S Curr Opin Organ Transplant; 2009 Dec; 14(6):656-61. PubMed ID: 19741534 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]